University of Alberta will start recruiting patients (15 all told) for a Phase 1 Newly diagnosed Glioblastoma trial, sponsord by the Alberta Cancer Board. The dosage is surprisingly low: 3mg/kg twice daily.
1. "RE: new DCA trial at U. of Alberta"
In response to message #0
Don't know what the Alberta Cancer Board is, but such a low dose may guarantee failure, which is useful if you want to point to a study that 'proves' a drug is not effective.
2. "RE: new DCA trial at U. of Alberta"
In response to message #1
i wonder if this might be a clue that the first trials look promising. Dr. M seems to be holding his cards tightly to his chest. he hasnt updated his web page since sept. 24th, 2007.